Director Ian T. Clark resigns from Agios board effective after 2022 annual meeting

AGIOS PHARMACEUTICALS, INC.

Ian T. Clark resigns as director effective immediately following the 2022 annual meeting.
Clark also steps down from Compensation & People and Nominating & Corporate Governance committees.
Company states resignation not related to any disagreement over operations, policies, or practices.
No replacement director announced as of April 25, 2022.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Ian T. Clark

Director

AGIO · AGIOS PHARMACEUTICALS, INC.

Filed: April 26, 2022, 7:59 PM ET

On April 25, 2022, Ian T. Clark notified Agios Pharmaceuticals, Inc. (the “Company”) of his decision to resign as a member of the Board, effective immediately following the 2022 annual meeting of stockholders.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ian T. Clark resigned as Director at AGIOS PHARMACEUTICALS, INC..

Action: resigned
Role: Director

Exact text from the filing

On April 25, 2022, Ian T. Clark notified Agios Pharmaceuticals, Inc. (the “Company”) of his decision to resign as a member of the Board, effective immediately following the 2022 annual meeting of stockholders.

View on SEC.gov

AGIOS PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-22-120194

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.